Core Clinical Centers for the Cardiothoracic Surgical Trials Network Program
Page 2

Since its establishment, the network has been working towards various activities that are associated with surgical trials, but has also encountered unfortunate challenges and concerns in the process.

Just like other surgical trials, the CTSN has faced quite a number of hurdles although current trials are anticipated to complete enrollment within the initial grant budget, there remains to be a strong need for better approaches to identify, recruit, randomize, and retain patients and logistically manage the cardiothoracic trials.

As a result, the funding agencies decided to launch the program in focus, hoping to solicit for experienced Core Clinical Centers (CCCs) that possess the ability to propose and execute innovative strategies to successfully operate trials within the purview of the CTSN.

The successful applicants of this program will be joining the network for a maximum period of 5 years and will be granted annual funds in the amount of $4,040,000.

The organizations and institutions who will be assumed eligible to submit an application under this program are the following:

a) Public/State Controlled Institutions of Higher Education
and Private Institutions of Higher Education

b) Nonprofit Organizations and Institutions

c) For-profit Organizations Such as Small Businesses

d) State and County Governments

e) City or Township Governments

f) Independent School Districts

g) Faith-based or Community-based Organizations

Core Clinical Centers for the Cardiothoracic Surgical Trials Network Program
  Back to Page 1

About The Author Michael Saunders is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs. He also maintains Websites providing resources on environmental grants and grants for youth programs.

Additional Resources

category - Health Grants

Development of Therapeutics and Diagnostics for Biodefense Program
The National Institutes of Health, in partnership with the National Institute of Allergy and Infectious Diseases(NIAID), has established the Development of Therapeutics and Diagnostics for Biodefense Program in an attempt to seek research proposals that desire to support the development of lead candidate diagnostics or therapeutics against NIAID Category A, B, or C priority agents.

---

Exploratory Clinical Trials for Small Business Grant Program
The National Institutes of Health has formed a partnership with the National Institute of Neurological Disorders and Stroke (NINDS) in order to establish the Exploratory Clinical Trials for Small Business Grant Program wherein they aim to establish a vehicle for Small Business Concerns (SBCs) in the process of submitting Small Business Technology Transfer (STTR) grant applications for exploratory clinical trials directly to the NIND

---

Excellence in Hemoglobinopathies Research Award Program
The National Institutes of Health has formed a collaboration with the National Heart, Lung, and Blood Institute (NHLBI) in an effort to establish the Excellence in Hemoglobinopathies Research Award Program wherein both agencies have agreed to financially support the creation of studies that could potentially improve high-impact multi-disciplinary basic and translational research studies in the hemoglobinopathies.

---

Small Business Innovation Research Phase IIB Bridge Awards
In line with this mission, the NIH has recently constituted the Small Business Innovation Research Phase IIB Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging Technologies, Interventional Devices, Diagnostics, and Prognostics Toward Commercialization Program.

---